Elevate! : An Elderly Breast Cancer Cohort Study

Exclusion Criteria

• •Any breast cancer subtype is allowed
• •Breast cancer-diagnosing biopsy within 90 days of enrollment
• •Receiving or will receive medical oncology care (+/- surgical and radiation oncology treatments) at the participating center: DFCI/satellites and affiliate sites
• •Patients must be able to understand, speak, and read English or assign a designated caregiver/proxy for the duration of the study who understands, speaks, and reads English and who is willing to assist with filling out the survey components which do not have a validated, translated version. This is because the surveys are not readily available in multiple languages as a whole, although some components (such as the Geriatric Assessment and PROs are readily available in multiple languages).
• •If a patient scores 11 or higher on the baseline Orientation-Memory-Concentration Test done at baseline (Appendix E), a proxy/designee must then be assigned to help the patient fill out the questionnaires for the duration of the study in order to participate. The treating provider will also be notified about the cognitive impairment.
• •Ability to provide informed consent
• •Pathological or clinical stage 0, IV disease
• •Those with nodal or metastatic recurrences at the time of enrollment
• •Unable to speak and read English AND no designee who speaks and reads English, as above
• •Unable to provide informed consent